For instance, higher ACE activity levels have been reported in patients with sarcoidosis but lower levels have been reported in those with fibrosing alveolitis, interstitial lung disease, and chronic obstructive lung disease [33]. This evidence concerns the gene ACE and chronic obstructive pulmonary disease.